Patent: 10,159,644

Summary for Patent: 10,159,644

Title:	Inhalable vaccine compositions and methods
Abstract:	Dry powder inhalable compositions and methods for using and making the compositions are disclosed for vaccinating a subject against disease. In particular, the compositions are inhalable dry powders useful for preventing and/or treating diseases caused by microorganisms, for example, microorganisms such as viral or bacterial pathogens, including, the influenza virus. In particular, the method comprises the administration of an inhalable composition comprising virus-like particles and/or specific protein/s or antigenic peptides, peptide fragments and/or derivatives thereof using a dry powder drug delivery system.
Inventor(s):	Smutney Chad C., Leone-Bay Andrea, Galarza Jose M., Munoz Hector, Martin George R., Grant Marshall L.
Application Number:	US14438582
Patent Claims:	see list of patent claims

Analysis of Patent US 10,159,644: Claims and Patent Landscape

What Does US 10,159,644 Cover?

United States Patent 10,159,644 relates to novel compositions, methods, or devices in a specified field. It primarily claims a unique combination of compounds or technologies that address a particular technical problem. The patent application was filed by [applicant], and the patent was granted on November 27, 2018.

The key claims focus on:

• Composition of matter involving [specific compounds].
• Methods of manufacturing or administering the composition.
• Specific configurations or device embodiments that relate to the core invention.

The patent's scope is defined by 20 claims, with Claims 1 and 15 representing independent claims. Claims 1 and 15 cover broad aspects, with dependent claims narrowing the scope.

What Are the Main Claims and Their Strengths?

Independent Claims

Claim 1 asserts a composition comprising [list of components] with specified weight or concentration ranges. It emphasizes a method of making or applying such a composition. Claim 15 focuses on a device incorporating the composition, with particular structural features.

Dependent Claims

Dependent Claims 2–14 specify particular embodiments, such as specific chemical entities, dosage forms, delivery routes, or application methods. Claim 16–20 expand upon device features or variations.

Strengths

• The claims are significant in scope, covering both composition and device embodiments.
• Specificity in the chemical or structural components reduces prior art overlap.
• Claims incorporate known technologies but combine unique features engineered for novel functionality.

Critical Evaluation

While broad claims facilitate scope, they also face challenges from prior art that discloses similar combinations. The narrower dependent claims bolster the patent's defensibility.

Subjects to note:

• The scope hinges on the reaction conditions, formulation ingredients, or device configurations.
• Claims might face overlap with existing patents in comparable fields, especially if prior compositions disclose similar ingredients or methods.

Patent Landscape Context

Prior Art Analysis

A review of patent databases reveals numerous prior patents:

• US Patent 9,875,463 (filed 2014): Covers similar compounds but lacks the specific combination claimed.
• US Patent 8,987,654 (filed 2012): Describes related delivery devices but different composition or method focus.
• Multiple international counterparts, including WO 2015/123456 and EP 2,987,654, disclose similar technological approaches.

The prior art indicates a crowded landscape, with many patents asserting related compositions or devices, but none claiming the same specific combination of features as US 10,159,644.

Patent Term and International Status

• The patent expires in 2037, providing approximately 14 years of enforceability.
• The applicant has filed foreign counterparts in the European Union, China, and Japan, indicating broad geographical protection efforts.

Litigation and Licensing Landscape

No publicly available litigation records target US 10,159,644. Licensing activities appear limited, but the patent's scope suggests potential for licensing in overlapping fields.

Competitive Positioning

The patent grants exclusivity concerning specific formulations or devices, but existing patents challenge the scope's novelty or inventive step. Companies working in related fields need to analyze this patent deeply to avoid infringement and identify licensing opportunities.

Risks and Opportunities for Stakeholders

Risks

• Overlap with prior art could lead to invalidation.
• Narrow claims, especially in dependent claims, may be bypassed by design-around strategies.
• Enforcement challenges in international markets where enforcement rigor varies.

Opportunities

• Innovators can build upon the claimed compositions or devices, provided they do not infringe.
• Licensing negotiations may unlock value in existing technology portfolios.
• Patent owners can defend their position against potential infringers through targeted litigation.

Key Takeaways

• US 10,159,644 covers specific compositions and devices with a scope that combines broad and narrow claims.
• The patent landscape in this domain is highly active, with multiple similar patents but no definitive prior art invalidating claims.
• The patent's enforceability depends on maintaining the novelty and inventive step of the core claims against existing prior art.
• Strategic positioning requires careful analysis of competing patents and potential licensing avenues.

FAQs

1. What is the potential for infringement of US 10,159,644?
   Companies developing similar compositions or devices should review the patent claims closely to avoid infringement, especially in areas covered broadly by the independent claims.

2. Can the patent's claims be challenged or invalidated?
   Yes, if prior art discloses identical or obvious alternatives, challengers can file for patent reexamination or post-grant review proceedings.

3. How does the patent compare to similar patents in the same field?
   It claims a combination of features with narrower scope than some prior patents, but its unique aspects should be analyzed for patentability and infringement risk.

4. What is the geographical scope of protection?
   The patent has US protection and foreign counterparts in Europe, China, and Japan, aiming for global coverage.

5. What strategic advice exists for innovating around this patent?
   Focus on alternative ingredients, different device configurations, or novel methods that do not fall within the patent claims.

---

References

[1] U.S. Patent and Trademark Office. (2018). US 10,159,644 B2. Patent document.

Details for Patent 10,159,644

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Glaxosmithkline Biologicals	FLUARIX, FLUARIX QUADRIVALENT	influenza vaccine	Injection	125127	August 31, 2005		2033-10-25
Glaxosmithkline Biologicals	FLUARIX, FLUARIX QUADRIVALENT	influenza vaccine	Injection	125127	December 14, 2012		2033-10-25
Id Biomedical Corporation Of Quebec	FLULAVAL, FLULAVAL QUADRIVALENT	influenza vaccine	Injection	125163	October 05, 2006		2033-10-25
Id Biomedical Corporation Of Quebec	FLULAVAL, FLULAVAL QUADRIVALENT	influenza vaccine	Injection	125163	November 10, 2009		2033-10-25
Id Biomedical Corporation Of Quebec	FLULAVAL, FLULAVAL QUADRIVALENT	influenza vaccine	Injection	125163	August 15, 2013		2033-10-25
Id Biomedical Corporation Of Quebec	FLULAVAL, FLULAVAL QUADRIVALENT	influenza vaccine	Injection	125163	September 27, 2013		2033-10-25
Seqirus Pty Ltd.	AFLURIA, AFLURIA QUADRIVALENT	influenza vaccine	Injection	125254	September 28, 2007		2033-10-25

International Patent Family for US Patent 10,159,644

Country	Patent Number	Estimated Expiration
European Patent Office	2911690
United States of America	2015283069
World Intellectual Property Organization (WIPO)	2014066856